Cargando…
Can we validate a clinical score to predict the risk of severe infection in patients with systemic lupus erythematosus? A longitudinal retrospective study in a British Cohort
OBJECTIVE: Severe infections are a major cause of morbidity and mortality in patients with systemic lupus erythematosus (SLE). Our primary objective was to use data from a large Spanish cohort to develop a risk score for severe infection in SLE, the SLE Severe Infection Score (SLESIS) and to validat...
Autores principales: | Tejera Segura, Beatriz, Rua-Figueroa, Iñigo, Pego-Reigosa, Jose Maria, del Campo, Victor, Wincup, Chris, Isenberg, David, Rahman, Anisur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589043/ https://www.ncbi.nlm.nih.gov/pubmed/31203250 http://dx.doi.org/10.1136/bmjopen-2018-028697 |
Ejemplares similares
-
Unmet Needs in the Pathogenesis and Treatment of Systemic Lupus Erythematosus
por: Bakshi, Jyoti, et al.
Publicado: (2017) -
Damage accrual and mortality over long-term follow-up in 300 patients with
systemic lupus erythematosus in a multi-ethnic British cohort
por: Segura, Beatriz Tejera, et al.
Publicado: (2019) -
Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohort
por: Segura, Beatriz Tejera, et al.
Publicado: (2019) -
Assessment of Mean Platelet Volume in Patients with Systemic Lupus Erythematosus
por: Hartmann, Lisandra Torres, et al.
Publicado: (2018) -
Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT Lupus) protocol: a prospective multicentre, double-blind, randomised, placebo-controlled, 52-week phase II clinical trial
por: Jones, Alexis, et al.
Publicado: (2019)